FDA Label for Engystol

View Indications, Usage & Precautions

Engystol Product Label

The following document was submitted to the FDA by the labeler of this product Medinatura. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Description



Ingredient name

Potency

Quantity

Final dilution

Asclepias vincetoxicum

6X

6.6 μl

8.22X

Asclepias vincetoxicum

10X

6.6 μl

12.22X

Asclepias vincetoxicum

30X

6.6 μl

32.22X

Sulphur

4X

3.3 μl

6.52X

Sulphur

10X

3.3 μl

12.52X


Indications And Usage



Engystol® Injection Solution is a homeopathic drug product indicated for the support of the immune system to reduce severity and duration of symptoms in viral infections, particularly in the early stages of colds and influenza-like illnesses.


Dosage And Administration



General Considerations

• The dosage schedules listed below can be used as a general guide for the administration of Engystol® Injection Solution.

• Engystol® Injection Solution may be administered s.c., i.d., i.m., or i.v.

• The interval between injections is left to the discretion of the HCP, but should not exceed 1 ampule in 24 hours.

• Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard any unused ampule contents.

• Draw up required dose into syringe.

• Discard any unused ampule contents. Do not reuse ampule.

  • Only licensed practitioners with sufficient expertise in injecting drugs, including the respective route of administration, should administer the product.

  • Standard Dosage:

    Adults and children 12 years and older: 1 ml 1 to 3 times per 7 days.

    Children 6 to 11 years: 0.7 ml 1 to 3 times per 7 days.

    Children 2 to 5 years: 0.5 ml 1 to 3 times per 7 days.

    Acute Dosage:

    Adults and children 12 years and older: 1 ml daily, and then continue with standard dosage.

    Children 6 to 11 years: 0.7 ml daily, and then continue with standard dosage.

    Children 2 to 5 years: 0.5 ml daily, and then continue with standard dosage.


Contraindications



Engystol® Injection Solution is contraindicated in patients with known hypersensitivity to Engystol® or any of its ingredients.


Warnings And Precautions



None


Adverse Reactions



Post-marketing Experience

• The following adverse events have been identified during post-marketing use of Engystol® Injection Solution. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

• Allergic (hypersensitivity) skin reactions may occur in isolated cases.

To report SUSPECTED ADVERSE REACTIONS, contact MediNatura. at 1.844.633.4628 or [email protected] or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch


Overdosage



No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.


Clinical Pharmacology



Mechanism of Action

The exact mechanism of Engystol® Injection Solution is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.


Dosage



1 ampule containing 1.1 ml solution for injection each containing the active ingredients in the strengths listed under Description.


* Please review the disclaimer below.